Evidence map›Paper›PMID 39520135›Full record

SynthesisAnnals of medicine2024

Enamel matrix derivative in the treatment of tooth replantation: from a biological basis to clinical application.

Yao Lin, Liangping Chen, Yuling Xu, Mingwei Xu, Qinghua Liu, Junbing He

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Annals of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yao LinJieyang Medical Research Center, Jieyang People's Hospital, Jieyang, Guangdong, China.ORCID 0000-0002-2726-2911
Liangping ChenThe Medical Supplies Room, Guigang City health Service Center, Guigang, Guangxi, China.
Yuling XuThe Department of Stomatology, Jieyang People's Hospital, Jieyang, Guangdong, China.
Mingwei XuJieyang Medical Research Center, Jieyang People's Hospital, Jieyang, Guangdong, China.
Qinghua LiuJieyang Medical Research Center, Jieyang People's Hospital, Jieyang, Guangdong, China.ORCID 0000-0002-6385-5482
Junbing HeJieyang Medical Research Center, Jieyang People's Hospital, Jieyang, Guangdong, China.ORCID 0000-0002-6916-4770

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn efficient therapeutic strategy for patients with replanted teeth has been extremely challenging because complete displacement of the teeth is inevitably accompanied by severe damage to periodontal tissue. Enamel matrix derivative (EMD) shows promise for periodontal regeneration, but its effects on replanted teeth remain unknown. This study systematically summarized the biological basis of EMD in replantation dental therapy and assessed its effect on clinical prognosis.

methodsPotential studies were searched

resultsA total of 329 patients with 375 replanted teeth met the inclusion criteria. Our pooling results indicated that EMD did not provide a numerical advantage for restoring normal PDL healing in replanted teeth (RR=0.38,

conclusionFor patients with replanted teeth, EMD treatment may not result in a numerical increase in normal PDL healing. However, as a biological regulator, EMD may arrest the progression of resorption, thus reducing the risk of extraction in the early stage. Well-designed randomized trials are required to validate these results due to the poor quality of evidence.

Indexed as

Dental Enamel ProteinsTooth ReplantationHumansPeriodontal LigamentRoot ResorptionTooth AvulsionDental Enamel Proteinsenamel matrix proteinsEnamel matrix derivativeperiodontal healingreplanted teethroot adsorptionsurvival

Identifiers

PMID39520135
PMCPMC11552275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.